Contemporary Antiretroviral Therapy Dysregulates Iron Transport and Augments Mitochondrial Dysfunction in HIV-Infected Human Microglia and Neural-Lineage Cells

Abstract

HIV-associated cognitive dysfunction during combination antiretroviral therapy (cART) involves mitochondrial dysfunction, but the impact of contemporary cART on chronic metabolic changes in the brain and in latent HIV infection is unclear. We interrogated mitochondrial function in a human microglia (hμglia) cell line harboring inducible HIV provirus and in SH-SY5Y cells after exposure to individual antiretroviral drugs or cART, using the MitoStress assay. cART-induced changes in protein expression, reactive oxygen species (ROS) production, mitochondrial DNA copy number, and cellular iron were also explored. Finally, we evaluated the ability of ROS scavengers or plasmid-mediated overexpression of the antioxidant iron-binding protein, Fth1, to reverse mitochondrial defects. Contemporary antiretroviral drugs, particularly bictegravir, depressed multiple facets of mitochondrial function by 20–30%, with the most pronounced effects in latently infected HIV+ hμglia and SH-SY5Y cells. Latently HIV-infected hμglia exhibited upregulated glycolysis. Increases in total and/or mitochondrial ROS, mitochondrial DNA copy number, and cellular iron accompanied mitochondrial defects in hμglia and SH-SY5Y cells. In SH-SY5Y cells, cART reduced mitochondrial iron–sulfur-cluster-containing supercomplex and subunit expression and increased Nox2 expression. Fth1 overexpression or pre-treatment with N-acetylcysteine prevented cART-induced mitochondrial dysfunction. Contemporary cART impairs mitochondrial bioenergetics in hμglia and SH-SY5Y cells, partly through cellular iron accumulation; some effects differ by HIV latency.

Association between urinary metals and prostate-specific antigen in aging population with depression: a cross-sectional study

“…Chronic inflammation caused by beryllium is considered a possible contributor to the carcinogenicity of beryllium to humans ( 24 , 48 ). Currently, there is no research analyzing the synergistic effects of Cd and depression on PSA, and in an era where mental health has a significant impact, further research on the mechanisms and preventive measures is warranted ( 12 , 14 , 42 ).…”

Mitochondrial Oxidative Phosphorylation in Viral Infections

“…PBMCs from non-treated HIV-infected patients were found to have reduced CII, III, and IV activities [99]. We have recently shown in glial cells that the inhibitory effect of antiretrovirals on SDH is abrogated in the presence of latent or active HIV infection [100]. Effects of viral proteins on the ETC as a result of direct interaction have also been described.…”

Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments

“…100 There are several NRTIs (eg, tenofovir, abacavir), NNRTIs (eg, efavirenz, rilpivirine, nevirapine), PIs (eg, atazanavir, darunavir, indinavir, ritonavir, saquinavir), and integrase strand transfer inhibitors (eg, dolutegravir, elvitegravir), which may be associated with mitochondrial dysfunction. 14 In general, studies have shown that combination ART can cause mitochondrial dysfunction in neurodegenerative disease states, 101 but studies in CVD remain more limited. The START trial (Strategic Timing of Antiretroviral Treatment) showed that, generally, CVD risk was insignificant between early or deferred ART, 102 suggesting that temporality is not principally governing the Mitochondria are the site of cellular respiration and ATP generation, as well as critical in the pathology of many diseases.…”